Empery Asset Management »

Sellas Life Sciences Group I shares owned by Empery Asset Management

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $623k 309k 2.02
2022-06-30 $2.1M 928k 2.23

More positions owned by Empery Asset Management

89bio (ETNB)
Unity Biotechnology
Fat Brands *w Exp 07/16/202 (FATBW)
Greenwave Technology Solutio
Polished *w Exp 06/02/202 (POLWQ)
Sobr Safe (SOBR)
Mind Medicine Mindmed (MNMD)
Tc Biopharm Holdings *w Exp 02/08/202 (TCBPW)
Sellas Life Sciences Group I (SLS)
Medicenna Therapeutics Corp. (MDNAF)
Harbor Custom Development In *w Exp 10/04/202 (HCDZQ)
Hagerty *w Exp 12/02/202 (HGTY.WS)
Surrozen
Athenex
Surgepays *w Exp 10/22/202 (SURGW)

View all positions for Empery Asset Management

Top funds holding Sellas Life Sciences Group I

Vanguard Group
Susquehanna International
Frigate Ventures
Geode Capital Management
BlackRock
Citadel Advisors
Opus Capital Group
State Street Corporation
Diametric Capital
Northern Trust
Renaissance Technologies
Virtu Financial
XTX Topco
Springbok Capital Management
LPL Financial

View all funds holding Sellas Life Sciences Group I